An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

Abstract The advent of dose intensified interval compressed therapy has improved event-free survival for patients with localized Ewing sarcoma (EwS) to 78% at 5 years. However, nearly a quarter of patients with localized tumors and 60–80% of patients with metastatic tumors suffer relapse and die of...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	David S. Shulman, Sarah B. Whittle, Didier Surdez, Kelly M. Bailey, Enrique de Álava, Jason T. Yustein, Adam Shlien, Masanori Hayashi, Alexander J. R. Bishop, Brian D. Crompton, Steven G. DuBois, Neerav Shukla, Patrick J. Leavey, Stephen L. Lessnick, Heinrich Kovar, Olivier Delattre, Thomas G. P. Grünewald, Cristina R. Antonescu, Ryan D. Roberts, Jeffrey A. Toretsky, Franck Tirode, Richard Gorlick, Katherine A. Janeway, Damon Reed, Elizabeth R. Lawlor, Patrick J. Grohar
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2022-09-01
Serier:	npj Precision Oncology
Online adgang:	https://doi.org/10.1038/s41698-022-00307-2
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!